We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
Two investigators supported by the NIHR Maudsley Biomedical Research Centre (BRC) have been appointed to the NIHR College of Senior Investigators for 2019. The appointees were named in the 12th round of the NIHR Senior Investigator competition.
By NIHR Maudsley BRC at 15 Mar 2019Researchers at King’s College London launched the largest ever single study of depression and anxiety in September 2018, recruiting in England, and are now opening the study in Northern Ireland, Scotland, and Wales. By recruiting at least 40,000 people who have experienced either depression or anxiety at some point in their life, the Genetic Links to Anxiety and Depression (GLAD) study will make important strides towards better understanding of these disorders and improving the lives of future patients.
By NIHR Maudsley BRC at 25 Feb 2019Researchers from the NIHR Maudsley BRC are to lead a pioneering new study into a cannabis-based treatment for people living with dementia. Alzheimer’s Research UK has awarded over £250,000 for the landmark phase II clinical trial of Sativex®, a cannabis-based medicine licenced in the UK. The drug has already been found to be safe in people and has been approved for use in the treatment of muscle stiffness and tightness experienced by people with multiple sclerosis. However, Sativex® is not currently licensed in the UK for any other indication, including treatment of the symptoms of dementia.
By NIHR Maudsley BRC at 21 Feb 2019
Dr Marcella Fok and Dr Chin-Kuo Chang used CRIS to look at the physical health of people diagnosed with a personality disorder.
By NIHR Maudsley BRC at 13 Feb 2019Oxytocin, a hormone most often associated with childbirth, is also known for its effects on social-emotional cognition and behaviour. According to new research supported by the NIHR Maudsley BRC, oxytocin also alters blood flow in the hippocampus — a brain region strongly implicated in the onset of psychosis — in those at clinically high risk of psychosis.
By NIHR Maudsley BRC at 12 Feb 2019
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2024 | Website design by CSMB Design | All rights reserved.
